Technical Assistance Webinar: HEAL KIDS (Knowledge, Innovation and Discovery Studies) Pain (U01/U24)

Tammara L. Jenkins, MSN, RN, PCNS-BC, FCCM, Program Officer, Eunice Kennedy Shriver National Institute of Child Health and Human Development

Tammara Jenkins is a board-certified Pediatric Advanced Practice Nurse and Program Officer in the Pediatric Trauma and Critical Illness Branch of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health. She is the Director of the PTCIB “Ethical, Translational, and Applied Research in Pediatric Critical Care Practice” research portfolio in the Pediatric Critical Care Research Program, as well as the Program Officer for the NICHD Collaborative Pediatric Critical Care Research Network.

Ms. Jenkins has extensive experience in both critical and acute care pediatric nursing. She completed her Bachelor of Science in Nursing degree at the California State University, Long Beach, and her Master of Science in Nursing, with a concentration in Critical Care Pediatrics, at the University of Pennsylvania. In 2019, she was elected as a Fellow of the American College of Critical Care Medicine.

Perdita Taylor-Zapata, MD., Best Pharmaceuticals for Children Act (BPCA) Program Lead and NICHD Program Officer Obstetric and Pediatric Pharmacology and Therapeutics Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development

Perdita Taylor-Zapata, M.D., is a Physician with the Obstetric and Pediatric Pharmacology and Therapeutics Branch(OPPTB) at the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), where she leads the effort for the implementation of the Best Pharmaceuticals for Children Act (BPCA) at the NICHD. She is a pediatrician from the Washington Metropolitan area. She graduated from Howard University Medical School in 1994, and completed her pediatric residency training at the Children's National Medical Center in Washington, D.C. After her residency, she worked at the National Institutes of Health Clinical Center as a clinic physician in the Pediatric HIV Working Group of the National Cancer Institute. There she spent 7 years taking care of the outpatient and inpatient medical needs of the HIV-positive pediatric patients enrolled in phase I/II clinical treatment trials. In addition to her role as a staff physician, she was also involved in medical research, writing parts of clinical protocols and conducting retrospective and prospective research projects. Since 2004, she has worked in OPPTB, starting as the primary outreach liaison for the BPCA Program, then as the Program official for the BPCA Data Coordinating Center (DCC), and now as the primary program lead for the entire BPCA Program, including the Pediatric Trials Network, the DCC and the logistics contract team. In addition to pediatric drug development, Dr. Taylor-Zapata also has research interests in pharmacoepidemiology, workforce diversity, and adverse effects of medications used in children.